Metsera started at buy at Guggenheim on obesity treatment potential
Guggenheim has initiated Metsera at buy saying that the biotech's pipeline of injectable and oral nutrient stimulated hormone ...
standard-journal2d
Samsung Bioepis Announces US Launch of PYZCHIVA® (ustekinumab-ttwe), Biosimilar to Stelara
Samsung Bioepis Co., Ltd. today announced that PYZCHIVA ® (ustekinumab-ttwe), a biosimilar to Stelara (ustekinumab), is now available in the United States. PYZCHIVA has been approved for the treatment ...
Islet transplantation with blood vessel cells shows promise to treat type 1 diabetes
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...
GlobalData on MSN5d
J&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UC
Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate ...